Global Renin-Angiotensin-System (RAS)-Acting Agent Supply, Demand and Key Producers, 2023-2029
The global Renin-Angiotensin-System (RAS)-Acting Agent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Renin-Angiotensin-System (RAS)-Acting Agent production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Renin-Angiotensin-System (RAS)-Acting Agent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Renin-Angiotensin-System (RAS)-Acting Agent that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Renin-Angiotensin-System (RAS)-Acting Agent total production and demand, 2018-2029, (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent total production value, 2018-2029, (USD Million)
Global Renin-Angiotensin-System (RAS)-Acting Agent production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Renin-Angiotensin-System (RAS)-Acting Agent domestic production, consumption, key domestic manufacturers and share
Global Renin-Angiotensin-System (RAS)-Acting Agent production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Renin-Angiotensin-System (RAS)-Acting Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Sanofi S.A., Bristol-Myers Squibb Company, Daiichi Sankyo Company,Limited, Takeda Pharmaceutical Company Limited and Boehringer lngelheim GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Renin-Angiotensin-System (RAS)-Acting Agent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Renin-Angiotensin-System (RAS)-Acting Agent Market, By Region:
1. How big is the global Renin-Angiotensin-System (RAS)-Acting Agent market?
2. What is the demand of the global Renin-Angiotensin-System (RAS)-Acting Agent market?
3. What is the year over year growth of the global Renin-Angiotensin-System (RAS)-Acting Agent market?
4. What is the production and production value of the global Renin-Angiotensin-System (RAS)-Acting Agent market?
5. Who are the key producers in the global Renin-Angiotensin-System (RAS)-Acting Agent market?
6. What are the growth factors driving the market demand?
This report studies the global Renin-Angiotensin-System (RAS)-Acting Agent production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Renin-Angiotensin-System (RAS)-Acting Agent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Renin-Angiotensin-System (RAS)-Acting Agent that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Renin-Angiotensin-System (RAS)-Acting Agent total production and demand, 2018-2029, (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent total production value, 2018-2029, (USD Million)
Global Renin-Angiotensin-System (RAS)-Acting Agent production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Renin-Angiotensin-System (RAS)-Acting Agent domestic production, consumption, key domestic manufacturers and share
Global Renin-Angiotensin-System (RAS)-Acting Agent production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Renin-Angiotensin-System (RAS)-Acting Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Sanofi S.A., Bristol-Myers Squibb Company, Daiichi Sankyo Company,Limited, Takeda Pharmaceutical Company Limited and Boehringer lngelheim GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Renin-Angiotensin-System (RAS)-Acting Agent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Renin-Angiotensin-System (RAS)-Acting Agent Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Angiotensin Converting Enzyme Inhibitors (ACEi)
- Angiotensin Receptor Blockers (ARBs)
- Hypertension
- Heart Failure
- Chronic Kidney Disease
- Other
- Novartis AG
- Pfizer, Inc.
- AstraZeneca plc
- Merck & Co., Inc.
- Sanofi S.A.
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company,Limited
- Takeda Pharmaceutical Company Limited
- Boehringer lngelheim GmbH
- Johnson & Johnson
1. How big is the global Renin-Angiotensin-System (RAS)-Acting Agent market?
2. What is the demand of the global Renin-Angiotensin-System (RAS)-Acting Agent market?
3. What is the year over year growth of the global Renin-Angiotensin-System (RAS)-Acting Agent market?
4. What is the production and production value of the global Renin-Angiotensin-System (RAS)-Acting Agent market?
5. Who are the key producers in the global Renin-Angiotensin-System (RAS)-Acting Agent market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Renin-Angiotensin-System (RAS)-Acting Agent Introduction
1.2 World Renin-Angiotensin-System (RAS)-Acting Agent Supply & Forecast
1.2.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018 & 2022 & 2029)
1.2.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.2.3 World Renin-Angiotensin-System (RAS)-Acting Agent Pricing Trends (2018-2029)
1.3 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (Based on Production Site)
1.3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2018-2029)
1.3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (2018-2029)
1.3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2029)
1.3.4 North America Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.3.5 Europe Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.3.6 China Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.3.7 Japan Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Renin-Angiotensin-System (RAS)-Acting Agent Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Renin-Angiotensin-System (RAS)-Acting Agent Demand (2018-2029)
2.2 World Renin-Angiotensin-System (RAS)-Acting Agent Consumption by Region
2.2.1 World Renin-Angiotensin-System (RAS)-Acting Agent Consumption by Region (2018-2023)
2.2.2 World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Forecast by Region (2024-2029)
2.3 United States Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.4 China Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.5 Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.6 Japan Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.7 South Korea Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.8 ASEAN Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.9 India Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
3 WORLD RENIN-ANGIOTENSIN-SYSTEM (RAS)-ACTING AGENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Manufacturer (2018-2023)
3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Manufacturer (2018-2023)
3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023)
3.4 Renin-Angiotensin-System (RAS)-Acting Agent Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Renin-Angiotensin-System (RAS)-Acting Agent in 2022
3.5.3 Global Concentration Ratios (CR8) for Renin-Angiotensin-System (RAS)-Acting Agent in 2022
3.6 Renin-Angiotensin-System (RAS)-Acting Agent Market: Overall Company Footprint Analysis
3.6.1 Renin-Angiotensin-System (RAS)-Acting Agent Market: Region Footprint
3.6.2 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
3.6.3 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Comparison
4.1.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Comparison
4.2.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Comparison
4.3.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018-2023)
4.4.3 United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023)
4.5 China Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers and Market Share
4.5.1 China Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018-2023)
4.5.3 China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023)
4.6 Rest of World Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Renin-Angiotensin-System (RAS)-Acting Agent Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Angiotensin Converting Enzyme Inhibitors (ACEi)
5.2.2 Angiotensin Receptor Blockers (ARBs)
5.3 Market Segment by Type
5.3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Type (2018-2029)
5.3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type (2018-2029)
5.3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Renin-Angiotensin-System (RAS)-Acting Agent Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hypertension
6.2.2 Heart Failure
6.2.3 Chronic Kidney Disease
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Application (2018-2029)
6.3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application (2018-2029)
6.3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Details
7.1.2 Novartis AG Major Business
7.1.3 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.1.4 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis AG Recent Developments/Updates
7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Details
7.2.2 Pfizer, Inc. Major Business
7.2.3 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.2.4 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer, Inc. Recent Developments/Updates
7.2.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Details
7.3.2 AstraZeneca plc Major Business
7.3.3 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.3.4 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca plc Recent Developments/Updates
7.3.6 AstraZeneca plc Competitive Strengths & Weaknesses
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Details
7.4.2 Merck & Co., Inc. Major Business
7.4.3 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.4.4 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck & Co., Inc. Recent Developments/Updates
7.4.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Details
7.5.2 Sanofi S.A. Major Business
7.5.3 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.5.4 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi S.A. Recent Developments/Updates
7.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Details
7.6.2 Bristol-Myers Squibb Company Major Business
7.6.3 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.6.4 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.7 Daiichi Sankyo Company,Limited
7.7.1 Daiichi Sankyo Company,Limited Details
7.7.2 Daiichi Sankyo Company,Limited Major Business
7.7.3 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.7.4 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Daiichi Sankyo Company,Limited Recent Developments/Updates
7.7.6 Daiichi Sankyo Company,Limited Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Details
7.8.2 Takeda Pharmaceutical Company Limited Major Business
7.8.3 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.8.4 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.9 Boehringer lngelheim GmbH
7.9.1 Boehringer lngelheim GmbH Details
7.9.2 Boehringer lngelheim GmbH Major Business
7.9.3 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.9.4 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Boehringer lngelheim GmbH Recent Developments/Updates
7.9.6 Boehringer lngelheim GmbH Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.10.4 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Renin-Angiotensin-System (RAS)-Acting Agent Industry Chain
8.2 Renin-Angiotensin-System (RAS)-Acting Agent Upstream Analysis
8.2.1 Renin-Angiotensin-System (RAS)-Acting Agent Core Raw Materials
8.2.2 Main Manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Renin-Angiotensin-System (RAS)-Acting Agent Production Mode
8.6 Renin-Angiotensin-System (RAS)-Acting Agent Procurement Model
8.7 Renin-Angiotensin-System (RAS)-Acting Agent Industry Sales Model and Sales Channels
8.7.1 Renin-Angiotensin-System (RAS)-Acting Agent Sales Model
8.7.2 Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Renin-Angiotensin-System (RAS)-Acting Agent Introduction
1.2 World Renin-Angiotensin-System (RAS)-Acting Agent Supply & Forecast
1.2.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018 & 2022 & 2029)
1.2.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.2.3 World Renin-Angiotensin-System (RAS)-Acting Agent Pricing Trends (2018-2029)
1.3 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (Based on Production Site)
1.3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2018-2029)
1.3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (2018-2029)
1.3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2029)
1.3.4 North America Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.3.5 Europe Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.3.6 China Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.3.7 Japan Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Renin-Angiotensin-System (RAS)-Acting Agent Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Renin-Angiotensin-System (RAS)-Acting Agent Demand (2018-2029)
2.2 World Renin-Angiotensin-System (RAS)-Acting Agent Consumption by Region
2.2.1 World Renin-Angiotensin-System (RAS)-Acting Agent Consumption by Region (2018-2023)
2.2.2 World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Forecast by Region (2024-2029)
2.3 United States Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.4 China Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.5 Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.6 Japan Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.7 South Korea Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.8 ASEAN Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
2.9 India Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029)
3 WORLD RENIN-ANGIOTENSIN-SYSTEM (RAS)-ACTING AGENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Manufacturer (2018-2023)
3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Manufacturer (2018-2023)
3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023)
3.4 Renin-Angiotensin-System (RAS)-Acting Agent Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Renin-Angiotensin-System (RAS)-Acting Agent in 2022
3.5.3 Global Concentration Ratios (CR8) for Renin-Angiotensin-System (RAS)-Acting Agent in 2022
3.6 Renin-Angiotensin-System (RAS)-Acting Agent Market: Overall Company Footprint Analysis
3.6.1 Renin-Angiotensin-System (RAS)-Acting Agent Market: Region Footprint
3.6.2 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
3.6.3 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Comparison
4.1.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Comparison
4.2.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Comparison
4.3.1 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018-2023)
4.4.3 United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023)
4.5 China Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers and Market Share
4.5.1 China Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018-2023)
4.5.3 China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023)
4.6 Rest of World Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Renin-Angiotensin-System (RAS)-Acting Agent Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Angiotensin Converting Enzyme Inhibitors (ACEi)
5.2.2 Angiotensin Receptor Blockers (ARBs)
5.3 Market Segment by Type
5.3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Type (2018-2029)
5.3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type (2018-2029)
5.3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Renin-Angiotensin-System (RAS)-Acting Agent Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hypertension
6.2.2 Heart Failure
6.2.3 Chronic Kidney Disease
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Renin-Angiotensin-System (RAS)-Acting Agent Production by Application (2018-2029)
6.3.2 World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application (2018-2029)
6.3.3 World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Details
7.1.2 Novartis AG Major Business
7.1.3 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.1.4 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis AG Recent Developments/Updates
7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Details
7.2.2 Pfizer, Inc. Major Business
7.2.3 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.2.4 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer, Inc. Recent Developments/Updates
7.2.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Details
7.3.2 AstraZeneca plc Major Business
7.3.3 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.3.4 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca plc Recent Developments/Updates
7.3.6 AstraZeneca plc Competitive Strengths & Weaknesses
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Details
7.4.2 Merck & Co., Inc. Major Business
7.4.3 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.4.4 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck & Co., Inc. Recent Developments/Updates
7.4.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Details
7.5.2 Sanofi S.A. Major Business
7.5.3 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.5.4 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi S.A. Recent Developments/Updates
7.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Details
7.6.2 Bristol-Myers Squibb Company Major Business
7.6.3 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.6.4 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.7 Daiichi Sankyo Company,Limited
7.7.1 Daiichi Sankyo Company,Limited Details
7.7.2 Daiichi Sankyo Company,Limited Major Business
7.7.3 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.7.4 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Daiichi Sankyo Company,Limited Recent Developments/Updates
7.7.6 Daiichi Sankyo Company,Limited Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Details
7.8.2 Takeda Pharmaceutical Company Limited Major Business
7.8.3 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.8.4 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.9 Boehringer lngelheim GmbH
7.9.1 Boehringer lngelheim GmbH Details
7.9.2 Boehringer lngelheim GmbH Major Business
7.9.3 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.9.4 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Boehringer lngelheim GmbH Recent Developments/Updates
7.9.6 Boehringer lngelheim GmbH Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
7.10.4 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Renin-Angiotensin-System (RAS)-Acting Agent Industry Chain
8.2 Renin-Angiotensin-System (RAS)-Acting Agent Upstream Analysis
8.2.1 Renin-Angiotensin-System (RAS)-Acting Agent Core Raw Materials
8.2.2 Main Manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Renin-Angiotensin-System (RAS)-Acting Agent Production Mode
8.6 Renin-Angiotensin-System (RAS)-Acting Agent Procurement Model
8.7 Renin-Angiotensin-System (RAS)-Acting Agent Industry Sales Model and Sales Channels
8.7.1 Renin-Angiotensin-System (RAS)-Acting Agent Sales Model
8.7.2 Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2018-2023) & (USD Million)
Table 3. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2024-2029) & (USD Million)
Table 4. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Region (2018-2023)
Table 5. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Region (2024-2029)
Table 6. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (2018-2023) & (K Units)
Table 7. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (2024-2029) & (K Units)
Table 8. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Region (2018-2023)
Table 9. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Region (2024-2029)
Table 10. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Renin-Angiotensin-System (RAS)-Acting Agent Major Market Trends
Table 13. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption by Region (2018-2023) & (K Units)
Table 15. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Renin-Angiotensin-System (RAS)-Acting Agent Producers in 2022
Table 18. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Renin-Angiotensin-System (RAS)-Acting Agent Producers in 2022
Table 20. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Renin-Angiotensin-System (RAS)-Acting Agent Company Evaluation Quadrant
Table 22. World Renin-Angiotensin-System (RAS)-Acting Agent Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Renin-Angiotensin-System (RAS)-Acting Agent Production Site of Key Manufacturer
Table 24. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
Table 25. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
Table 26. Renin-Angiotensin-System (RAS)-Acting Agent Competitive Factors
Table 27. Renin-Angiotensin-System (RAS)-Acting Agent New Entrant and Capacity Expansion Plans
Table 28. Renin-Angiotensin-System (RAS)-Acting Agent Mergers & Acquisitions Activity
Table 29. United States VS China Renin-Angiotensin-System (RAS)-Acting Agent Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Renin-Angiotensin-System (RAS)-Acting Agent Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Renin-Angiotensin-System (RAS)-Acting Agent Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share (2018-2023)
Table 37. China Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share (2018-2023)
Table 42. Rest of World Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share (2018-2023)
Table 47. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Type (2018-2023) & (K Units)
Table 49. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Type (2024-2029) & (K Units)
Table 50. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type (2018-2023) & (USD Million)
Table 51. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type (2024-2029) & (USD Million)
Table 52. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Application (2018-2023) & (K Units)
Table 56. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Application (2024-2029) & (K Units)
Table 57. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application (2018-2023) & (USD Million)
Table 58. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application (2024-2029) & (USD Million)
Table 59. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 64. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer, Inc. Major Business
Table 69. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 70. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer, Inc. Recent Developments/Updates
Table 72. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 73. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca plc Major Business
Table 75. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 76. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca plc Recent Developments/Updates
Table 78. AstraZeneca plc Competitive Strengths & Weaknesses
Table 79. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Merck & Co., Inc. Major Business
Table 81. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 82. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck & Co., Inc. Recent Developments/Updates
Table 84. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 85. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi S.A. Major Business
Table 87. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 88. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi S.A. Recent Developments/Updates
Table 90. Sanofi S.A. Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Company Major Business
Table 93. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 94. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Company Recent Developments/Updates
Table 96. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 97. Daiichi Sankyo Company,Limited Basic Information, Manufacturing Base and Competitors
Table 98. Daiichi Sankyo Company,Limited Major Business
Table 99. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 100. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Daiichi Sankyo Company,Limited Recent Developments/Updates
Table 102. Daiichi Sankyo Company,Limited Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Company Limited Major Business
Table 105. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 106. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 108. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 109. Boehringer lngelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 110. Boehringer lngelheim GmbH Major Business
Table 111. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 112. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Boehringer lngelheim GmbH Recent Developments/Updates
Table 114. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 115. Johnson & Johnson Major Business
Table 116. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 117. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Renin-Angiotensin-System (RAS)-Acting Agent Upstream (Raw Materials)
Table 119. Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
Table 120. Renin-Angiotensin-System (RAS)-Acting Agent Typical Distributors
Table 1. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2018-2023) & (USD Million)
Table 3. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Region (2024-2029) & (USD Million)
Table 4. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Region (2018-2023)
Table 5. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Region (2024-2029)
Table 6. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (2018-2023) & (K Units)
Table 7. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Region (2024-2029) & (K Units)
Table 8. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Region (2018-2023)
Table 9. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Region (2024-2029)
Table 10. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Renin-Angiotensin-System (RAS)-Acting Agent Major Market Trends
Table 13. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption by Region (2018-2023) & (K Units)
Table 15. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Renin-Angiotensin-System (RAS)-Acting Agent Producers in 2022
Table 18. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Renin-Angiotensin-System (RAS)-Acting Agent Producers in 2022
Table 20. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Renin-Angiotensin-System (RAS)-Acting Agent Company Evaluation Quadrant
Table 22. World Renin-Angiotensin-System (RAS)-Acting Agent Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Renin-Angiotensin-System (RAS)-Acting Agent Production Site of Key Manufacturer
Table 24. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
Table 25. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
Table 26. Renin-Angiotensin-System (RAS)-Acting Agent Competitive Factors
Table 27. Renin-Angiotensin-System (RAS)-Acting Agent New Entrant and Capacity Expansion Plans
Table 28. Renin-Angiotensin-System (RAS)-Acting Agent Mergers & Acquisitions Activity
Table 29. United States VS China Renin-Angiotensin-System (RAS)-Acting Agent Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Renin-Angiotensin-System (RAS)-Acting Agent Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Renin-Angiotensin-System (RAS)-Acting Agent Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share (2018-2023)
Table 37. China Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share (2018-2023)
Table 42. Rest of World Based Renin-Angiotensin-System (RAS)-Acting Agent Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share (2018-2023)
Table 47. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Type (2018-2023) & (K Units)
Table 49. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Type (2024-2029) & (K Units)
Table 50. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type (2018-2023) & (USD Million)
Table 51. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type (2024-2029) & (USD Million)
Table 52. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Application (2018-2023) & (K Units)
Table 56. World Renin-Angiotensin-System (RAS)-Acting Agent Production by Application (2024-2029) & (K Units)
Table 57. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application (2018-2023) & (USD Million)
Table 58. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application (2024-2029) & (USD Million)
Table 59. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 64. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer, Inc. Major Business
Table 69. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 70. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer, Inc. Recent Developments/Updates
Table 72. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 73. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca plc Major Business
Table 75. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 76. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca plc Recent Developments/Updates
Table 78. AstraZeneca plc Competitive Strengths & Weaknesses
Table 79. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Merck & Co., Inc. Major Business
Table 81. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 82. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck & Co., Inc. Recent Developments/Updates
Table 84. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 85. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi S.A. Major Business
Table 87. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 88. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi S.A. Recent Developments/Updates
Table 90. Sanofi S.A. Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Company Major Business
Table 93. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 94. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Company Recent Developments/Updates
Table 96. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 97. Daiichi Sankyo Company,Limited Basic Information, Manufacturing Base and Competitors
Table 98. Daiichi Sankyo Company,Limited Major Business
Table 99. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 100. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Daiichi Sankyo Company,Limited Recent Developments/Updates
Table 102. Daiichi Sankyo Company,Limited Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Company Limited Major Business
Table 105. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 106. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 108. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 109. Boehringer lngelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 110. Boehringer lngelheim GmbH Major Business
Table 111. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 112. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Boehringer lngelheim GmbH Recent Developments/Updates
Table 114. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 115. Johnson & Johnson Major Business
Table 116. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 117. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Renin-Angiotensin-System (RAS)-Acting Agent Upstream (Raw Materials)
Table 119. Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
Table 120. Renin-Angiotensin-System (RAS)-Acting Agent Typical Distributors
LIST OF FIGURES
Figure 1. Renin-Angiotensin-System (RAS)-Acting Agent Picture
Figure 2. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 5. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price (2018-2029) & (US$/Unit)
Figure 6. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Region (2018-2029)
Figure 7. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Region (2018-2029)
Figure 8. North America Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 9. Europe Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 10. China Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 11. Japan Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 12. Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 15. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Market Share by Region (2018-2029)
Figure 16. United States Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 17. China Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 18. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 19. Japan Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 20. South Korea Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 22. India Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Renin-Angiotensin-System (RAS)-Acting Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Renin-Angiotensin-System (RAS)-Acting Agent Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Renin-Angiotensin-System (RAS)-Acting Agent Markets in 2022
Figure 26. United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share 2022
Figure 30. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share 2022
Figure 32. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Type in 2022
Figure 34. Angiotensin Converting Enzyme Inhibitors (ACEi)
Figure 35. Angiotensin Receptor Blockers (ARBs)
Figure 36. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Type (2018-2029)
Figure 37. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Type (2018-2029)
Figure 38. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Application in 2022
Figure 41. Hypertension
Figure 42. Heart Failure
Figure 43. Chronic Kidney Disease
Figure 44. Other
Figure 45. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Application (2018-2029)
Figure 46. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Application (2018-2029)
Figure 47. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Renin-Angiotensin-System (RAS)-Acting Agent Industry Chain
Figure 49. Renin-Angiotensin-System (RAS)-Acting Agent Procurement Model
Figure 50. Renin-Angiotensin-System (RAS)-Acting Agent Sales Model
Figure 51. Renin-Angiotensin-System (RAS)-Acting Agent Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Renin-Angiotensin-System (RAS)-Acting Agent Picture
Figure 2. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 5. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price (2018-2029) & (US$/Unit)
Figure 6. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Region (2018-2029)
Figure 7. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Region (2018-2029)
Figure 8. North America Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 9. Europe Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 10. China Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 11. Japan Renin-Angiotensin-System (RAS)-Acting Agent Production (2018-2029) & (K Units)
Figure 12. Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 15. World Renin-Angiotensin-System (RAS)-Acting Agent Consumption Market Share by Region (2018-2029)
Figure 16. United States Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 17. China Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 18. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 19. Japan Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 20. South Korea Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 22. India Renin-Angiotensin-System (RAS)-Acting Agent Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Renin-Angiotensin-System (RAS)-Acting Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Renin-Angiotensin-System (RAS)-Acting Agent Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Renin-Angiotensin-System (RAS)-Acting Agent Markets in 2022
Figure 26. United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Renin-Angiotensin-System (RAS)-Acting Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share 2022
Figure 30. China Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share 2022
Figure 32. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Type in 2022
Figure 34. Angiotensin Converting Enzyme Inhibitors (ACEi)
Figure 35. Angiotensin Receptor Blockers (ARBs)
Figure 36. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Type (2018-2029)
Figure 37. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Type (2018-2029)
Figure 38. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Application in 2022
Figure 41. Hypertension
Figure 42. Heart Failure
Figure 43. Chronic Kidney Disease
Figure 44. Other
Figure 45. World Renin-Angiotensin-System (RAS)-Acting Agent Production Market Share by Application (2018-2029)
Figure 46. World Renin-Angiotensin-System (RAS)-Acting Agent Production Value Market Share by Application (2018-2029)
Figure 47. World Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Renin-Angiotensin-System (RAS)-Acting Agent Industry Chain
Figure 49. Renin-Angiotensin-System (RAS)-Acting Agent Procurement Model
Figure 50. Renin-Angiotensin-System (RAS)-Acting Agent Sales Model
Figure 51. Renin-Angiotensin-System (RAS)-Acting Agent Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
